IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q3 2021 Holdings

Filed 2021-11-15 | 14 holdings | $69.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals Inc(ARWR)COM04280A100$33.0M527,92647.6%
Arvinas Inc(ARVN)COM04335A105$29.2M354,71142.1%
Argenx SE(ARGX)SPONSORED ADR04016X101$6.7M22,2009.7%
Spdr S&P Biotech ETF TR(XBI)PutUNIT78464A870$125.7K1,000,0000.2%
Spero Therapeutics Inc(SPRO)COM84833T103$84.0K4,563,6880.1%
Blueprint Medicines Corp(2L9)COM09627Y109$53.6K521,6730.1%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$49.5K2,456,5950.1%
Uniqure NV(QURE)SHSN90064101$42.2K1,319,5130.1%
Regenxbio Inc(RGNX)COM75901B107$35.2K839,1390.1%
4D Molecular Therapeutics Inc(FDMT)COM35104E100$29.7K1,099,9440.0%
Magenta Therapeutics IncCOM55910K108$23.0K3,155,0820.0%
Amryt Pharma PLCSPONSORED ADS03217L106$16.7K1,390,0000.0%
Pieris Pharmaceuticals IncCOM720795103$16.5K3,196,5270.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$5.6K127,5000.0%